These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 22932871)

  • 21. Tumor cell invasion is promoted by interstitial flow-induced matrix priming by stromal fibroblasts.
    Shieh AC; Rozansky HA; Hinz B; Swartz MA
    Cancer Res; 2011 Feb; 71(3):790-800. PubMed ID: 21245098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantifying solid stress and elastic energy from excised or in situ tumors.
    Nia HT; Datta M; Seano G; Huang P; Munn LL; Jain RK
    Nat Protoc; 2018 May; 13(5):1091-1105. PubMed ID: 29674756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacologic modification of tumor blood flow and interstitial fluid pressure in a human tumor xenograft: network analysis and mechanistic interpretation.
    Zlotecki RA; Baxter LT; Boucher Y; Jain RK
    Microvasc Res; 1995 Nov; 50(3):429-43. PubMed ID: 8583955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solid tumor physiology and hypoxia-induced chemo/radio-resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer.
    Yasuda H
    Nitric Oxide; 2008 Sep; 19(2):205-16. PubMed ID: 18503779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accumulation of mechanical forces in tumors is related to hyaluronan content and tissue stiffness.
    Voutouri C; Stylianopoulos T
    PLoS One; 2018; 13(3):e0193801. PubMed ID: 29561855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of smoothened activates the sonic hedgehog signaling pathway in pancreatic cancer-associated fibroblasts.
    Walter K; Omura N; Hong SM; Griffith M; Vincent A; Borges M; Goggins M
    Clin Cancer Res; 2010 Mar; 16(6):1781-9. PubMed ID: 20215540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences between solid and duct-ectatic types of pancreatic ductal carcinomas.
    Furuta K; Watanabe H; Ikeda S
    Cancer; 1992 Mar; 69(6):1327-33. PubMed ID: 1540869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PG545, an angiogenesis and heparanase inhibitor, reduces primary tumor growth and metastasis in experimental pancreatic cancer.
    Ostapoff KT; Awasthi N; Cenik BK; Hinz S; Dredge K; Schwarz RE; Brekken RA
    Mol Cancer Ther; 2013 Jul; 12(7):1190-201. PubMed ID: 23696215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arousal of cancer-associated stroma: overexpression of palladin activates fibroblasts to promote tumor invasion.
    Brentnall TA; Lai LA; Coleman J; Bronner MP; Pan S; Chen R
    PLoS One; 2012; 7(1):e30219. PubMed ID: 22291919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imatinib increases oxygen delivery in extracellular matrix-rich but not in matrix-poor experimental carcinoma.
    Burmakin M; van Wieringen T; Olsson PO; Stuhr L; Åhgren A; Heldin CH; Reed RK; Rubin K; Hellberg C
    J Transl Med; 2017 Feb; 15(1):47. PubMed ID: 28231806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reengineering the Tumor Vasculature: Improving Drug Delivery and Efficacy.
    Stylianopoulos T; Munn LL; Jain RK
    Trends Cancer; 2018 Apr; 4(4):258-259. PubMed ID: 29606306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of tumor-associated stroma in promotion of intratumoral lymphangiogenesis: pivotal role of a hyaluronan-rich tumor microenvironment.
    Koyama H; Kobayashi N; Harada M; Takeoka M; Kawai Y; Sano K; Fujimori M; Amano J; Ohhashi T; Kannagi R; Kimata K; Taniguchi S; Itano N
    Am J Pathol; 2008 Jan; 172(1):179-93. PubMed ID: 18079437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ETS-Transcription Factor ETV1 Regulates Stromal Expansion and Metastasis in Pancreatic Cancer.
    Heeg S; Das KK; Reichert M; Bakir B; Takano S; Caspers J; Aiello NM; Wu K; Neesse A; Maitra A; Iacobuzio-Donahue CA; Hicks P; Rustgi AK
    Gastroenterology; 2016 Sep; 151(3):540-553.e14. PubMed ID: 27318148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The distribution of the anticancer drug Doxorubicin in relation to blood vessels in solid tumors.
    Primeau AJ; Rendon A; Hedley D; Lilge L; Tannock IF
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8782-8. PubMed ID: 16361566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meflin-Positive Cancer-Associated Fibroblasts Inhibit Pancreatic Carcinogenesis.
    Mizutani Y; Kobayashi H; Iida T; Asai N; Masamune A; Hara A; Esaki N; Ushida K; Mii S; Shiraki Y; Ando K; Weng L; Ishihara S; Ponik SM; Conklin MW; Haga H; Nagasaka A; Miyata T; Matsuyama M; Kobayashi T; Fujii T; Yamada S; Yamaguchi J; Wang T; Woods SL; Worthley D; Shimamura T; Fujishiro M; Hirooka Y; Enomoto A; Takahashi M
    Cancer Res; 2019 Oct; 79(20):5367-5381. PubMed ID: 31439548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activity.
    Loukopoulos P; Kanetaka K; Takamura M; Shibata T; Sakamoto M; Hirohashi S
    Pancreas; 2004 Oct; 29(3):193-203. PubMed ID: 15367885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ets-2 overexpression contributes to progression of pancreatic adenocarcinoma.
    Ito Y; Miyoshi E; Takeda T; Sakon M; Ihara S; Tsujimoto M; Matsuura N
    Oncol Rep; 2002; 9(4):853-7. PubMed ID: 12066221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An orthotopic model of ductal adenocarcinoma of the pancreas in severe combined immunodeficient mice representing all steps of the metastatic cascade.
    Alves F; Contag S; Missbach M; Kaspareit J; Nebendahl K; Borchers U; Heidrich B; Streich R; Hiddemann W
    Pancreas; 2001 Oct; 23(3):227-35. PubMed ID: 11590317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Solid stress generated by spheroid growth estimated using a linear poroelasticity model.
    Roose T; Netti PA; Munn LL; Boucher Y; Jain RK
    Microvasc Res; 2003 Nov; 66(3):204-12. PubMed ID: 14609526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in mice.
    Smith JP; Wang S; Nadella S; Jablonski SA; Weiner LM
    Cancer Immunol Immunother; 2018 Feb; 67(2):195-207. PubMed ID: 29043413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.